{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:47:02Z","timestamp":1791413222753,"version":"4.3.3"},"reference-count":0,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood"],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1182\/blood-2005-08-3430","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T21:48:10Z","timestamp":1134510490000},"page":"3455-3462","source":"Crossref","is-referenced-by-count":563,"title":["A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia"],"prefix":"10.1182","volume":"107","author":[{"given":"M. D.","family":"Cappellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","container-title":["Blood"],"original-title":[],"language":"en","deposited":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T10:48:11Z","timestamp":1314010091000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood-2005-08-3430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-08-3430","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13528.471012","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}